Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Gregory Fraser is an analyst at Truist Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/16/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/06/2025 | JAZZ | Buy Now | Jazz Pharmaceuticals | $101.55 | 126.49% | Gregory Fraser64% | $220 → $230 | Maintains | Buy | Get Alert |
| 10/22/2024 | ANIP | Buy Now | ANI Pharmaceuticals | $69.20 | -10.4% | Gregory Fraser64% | $60 → $62 | Maintains | Hold | Get Alert |
| 09/11/2024 | ANIP | Buy Now | ANI Pharmaceuticals | $69.20 | -13.29% | Gregory Fraser64% | $80 → $60 | Downgrade | Buy → Hold | Get Alert |
| 07/25/2024 | BHC | Buy Now | Bausch Health Companies | $4.55 | 53.85% | Gregory Fraser64% | $8 → $7 | Maintains | Hold | Get Alert |
| 04/30/2024 | XAIR | Buy Now | Beyond Air | $0.23 | 3360.21% | Gregory Fraser64% | $10 → $8 | Maintains | Buy | Get Alert |
| 03/01/2024 | ANIP | Buy Now | ANI Pharmaceuticals | $69.20 | 15.61% | Gregory Fraser64% | $72 → $80 | Maintains | Buy | Get Alert |
| 02/16/2024 | ANIP | Buy Now | ANI Pharmaceuticals | $69.20 | 4.05% | Gregory Fraser64% | $70 → $72 | Maintains | Buy | Get Alert |
| 01/18/2024 | BTMD | Buy Now | Biote | $3.31 | 171.9% | Gregory Fraser64% | $10 → $9 | Maintains | Buy | Get Alert |
| 11/14/2023 | XAIR | Buy Now | Beyond Air | $0.23 | 4225.26% | Gregory Fraser64% | $14 → $10 | Maintains | Buy | Get Alert |
| 11/08/2023 | AMRX | Buy Now | Amneal Pharmaceuticals | $7.29 | -3.98% | Gregory Fraser64% | $6 → $7 | Maintains | Buy | Get Alert |
| 09/06/2023 | AMRX | Buy Now | Amneal Pharmaceuticals | $7.29 | -17.7% | Gregory Fraser64% | → $6 | Reiterates | Buy → Buy | Get Alert |
| 08/21/2023 | ANIP | Buy Now | ANI Pharmaceuticals | $69.20 | 1.16% | Gregory Fraser64% | → $70 | Reiterates | Buy → Buy | Get Alert |
| 08/07/2023 | AMRX | Buy Now | Amneal Pharmaceuticals | $7.29 | -17.7% | Gregory Fraser64% | $4 → $6 | Maintains | Buy | Get Alert |
| 08/03/2023 | CORT | Buy Now | Corcept Therapeutics | $64.60 | -55.11% | Gregory Fraser64% | $26 → $29 | Maintains | Hold | Get Alert |
| 07/21/2023 | XAIR | Buy Now | Beyond Air | $0.23 | 5955.36% | Gregory Fraser64% | $18 → $14 | Maintains | Buy | Get Alert |
| 07/21/2023 | ANIP | Buy Now | ANI Pharmaceuticals | $69.20 | -13.29% | Gregory Fraser64% | $52 → $60 | Maintains | Buy | Get Alert |
| 06/06/2023 | NVCR | Buy Now | NovoCure | $15.83 | 500.13% | Gregory Fraser64% | → $95 | Reiterates | Buy → Buy | Get Alert |
| 05/26/2023 | EOLS | Buy Now | Evolus | $10.11 | 78.04% | Gregory Fraser64% | $14 → $18 | Maintains | Buy | Get Alert |
| 05/26/2023 | CORT | Buy Now | Corcept Therapeutics | $64.60 | -59.75% | Gregory Fraser64% | $28 → $26 | Maintains | Hold | Get Alert |
| 05/26/2023 | ARQT | Buy Now | Arcutis Biotherapeutics | $12.68 | 215.46% | Gregory Fraser64% | $45 → $40 | Maintains | Buy | Get Alert |
| 05/09/2023 | ANIP | Buy Now | ANI Pharmaceuticals | $69.20 | -24.86% | Gregory Fraser64% | $50 → $52 | Maintains | Buy | Get Alert |
| 03/29/2023 | AMRX | Buy Now | Amneal Pharmaceuticals | $7.29 | -45.13% | Gregory Fraser64% | $5 → $4 | Maintains | Buy | Get Alert |
| 03/29/2023 | ARQT | Buy Now | Arcutis Biotherapeutics | $12.68 | 254.89% | Gregory Fraser64% | $50 → $45 | Maintains | Buy | Get Alert |
| 11/08/2022 | CORT | Buy Now | Corcept Therapeutics | $64.60 | -56.66% | Gregory Fraser64% | $30 → $28 | Maintains | Hold | Get Alert |
| 10/28/2022 | NVCR | Buy Now | NovoCure | $15.83 | 544.35% | Gregory Fraser64% | $105 → $102 | Maintains | Buy | Get Alert |
| 09/27/2022 | BTMD | Buy Now | Biote | $3.31 | 202.11% | Gregory Fraser64% | → $10 | Initiates | → Buy | Get Alert |
| 08/24/2022 | AERI | Buy Now | Aerie Pharmaceuticals | — | — | Gregory Fraser64% | — | Downgrade | Buy → Hold | Get Alert |
| 08/01/2022 | CORT | Buy Now | Corcept Therapeutics | $64.60 | -53.56% | Gregory Fraser64% | → $30 | Downgrade | Buy → Hold | Get Alert |
| 07/29/2022 | NVCR | Buy Now | NovoCure | $15.83 | 563.3% | Gregory Fraser64% | $118 → $105 | Maintains | Buy | Get Alert |
| 07/29/2022 | BHC | Buy Now | Bausch Health Companies | $4.55 | — | Gregory Fraser64% | — | Downgrade | Buy → Hold | Get Alert |
| 06/29/2022 | XAIR | Buy Now | Beyond Air | $0.23 | 8550.52% | Gregory Fraser64% | $16 → $20 | Maintains | Buy | Get Alert |
| 05/17/2022 | CRXT | Buy Now | Clarus Therapeutics Hldgs | — | — | Gregory Fraser64% | $7 → $3 | Maintains | Buy | Get Alert |
| 04/14/2022 | ATRS | Buy Now | Antares Pharma | — | — | Gregory Fraser64% | $7 → $5.6 | Downgrade | Buy → Hold | Get Alert |
| 01/28/2022 | CORT | Buy Now | Corcept Therapeutics | $64.60 | -53.56% | Gregory Fraser64% | → $30 | Initiates | → Buy | Get Alert |
| 01/20/2022 | EOLS | Buy Now | Evolus | $10.11 | 8.8% | Gregory Fraser64% | → $11 | Upgrade | Hold → Buy | Get Alert |
| 11/12/2021 | XAIR | Buy Now | Beyond Air | $0.23 | 6820.42% | Gregory Fraser64% | $12 → $16 | Maintains | Buy | Get Alert |
| 11/02/2021 | ANIP | Buy Now | ANI Pharmaceuticals | $69.20 | 1.16% | Gregory Fraser64% | → $70 | Initiates | → Buy | Get Alert |
| 10/13/2021 | CRXT | Buy Now | Clarus Therapeutics Hldgs | — | — | Gregory Fraser64% | → $10 | Initiates | → Buy | Get Alert |
| 04/28/2021 | XAIR | Buy Now | Beyond Air | $0.23 | 5090.31% | Gregory Fraser64% | → $12 | Initiates | → Buy | Get Alert |
